1 April 2022 false No description of principal activity Taxfiler 2023.10.1 13241068business:PrivateLimitedCompanyLtd2022-04-012023-03-31 132410682022-03-31 132410682022-04-012023-03-31 13241068business:AuditExemptWithAccountantsReport2022-04-012023-03-31 13241068business:FilletedAccounts2022-04-012023-03-31 132410682023-03-31 13241068business:Director12022-04-012023-03-31 13241068business:RegisteredOffice2022-04-012023-03-31 132410682022-03-31 13241068core:WithinOneYear2023-03-31 13241068core:WithinOneYear2022-03-31 13241068core:ShareCapitalcore:PreviouslyStatedAmount2023-03-31 13241068core:ShareCapitalcore:PreviouslyStatedAmount2022-03-31 13241068core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-03-31 13241068core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2022-03-31 13241068core:PreviouslyStatedAmount2023-03-31 13241068core:PreviouslyStatedAmount2022-03-31 13241068business:SmallEntities2022-04-012023-03-31 13241068countries:EnglandWales2022-04-012023-03-31 13241068core:FurnitureFittings2022-04-012023-03-31 13241068core:ComputerEquipment2022-04-012023-03-31 13241068core:FurnitureFittings2022-03-31 13241068core:ComputerEquipment2022-03-31 13241068core:FurnitureFittings2023-03-31 13241068core:ComputerEquipment2023-03-31 13241068business:OrdinaryShareClass12022-04-012023-03-31 13241068business:OrdinaryShareClass12021-03-032022-03-31 13241068business:Director112022-04-012023-03-31 13241068business:Director112022-03-31 13241068business:Director112023-03-31 132410682021-03-032022-03-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 13241068 (England and Wales)
Antevasin Ltd Unaudited accounts for the year ended 31 March 2023
Antevasin Ltd Unaudited accounts Contents
Page
- 2 -
Antevasin Ltd Company Information for the year ended 31 March 2023
Director
Ms Beatrice Gallo
Company Number
13241068 (England and Wales)
Registered Office
8b Brick Lane London E1 6RF England
Accountants
TaxSense Accountants Ltd 203 West Street Fareham Hants PO16 0EN
- 3 -
Antevasin Ltd Accountants' report
Accountants' report to the director of Antevasin Ltd on the preparation of the unaudited statutory accounts for the year ended 31 March 2023
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Antevasin Ltd for the year ended 31 March 2023 as set out on pages 5 - 7 from the company's accounting records and from information and explanations you have given us.
This report is made solely to the Board of Directors of Antevasin Ltd, as a body, in accordance with the terms of our engagement. Our work has been undertaken solely to prepare for your approval the accounts of Antevasin Ltd and state those matters that we have agreed to state to them, as a body, in this report. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Antevasin Ltd and its Board of Directors as a body for our work or for this report.
It is your duty to ensure that Antevasin Ltd has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Antevasin Ltd. You consider that Antevasin Ltd is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the accounts of Antevasin Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.
TaxSense Accountants Ltd 203 West Street Fareham Hants PO16 0EN 23 October 2023
- 4 -
Antevasin Ltd Statement of financial position as at 31 March 2023
2023 
2022 
Notes
£ 
£ 
Fixed assets
Tangible assets
1,367 
916 
Current assets
Debtors
1,272 
3,193 
Cash at bank and in hand
8,286 
1,567 
9,558 
4,760 
Creditors: amounts falling due within one year
(7,606)
(4,692)
Net current assets
1,952 
68 
Net assets
3,319 
984 
Capital and reserves
Called up share capital
1 
1 
Profit and loss account
3,318 
983 
Shareholders' funds
3,319 
984 
For the year ending 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 23 October 2023 and were signed on its behalf by
Ms Beatrice Gallo Director Company Registration No. 13241068
- 5 -
Antevasin Ltd Notes to the Accounts for the year ended 31 March 2023
1
Statutory information
Antevasin Ltd is a private company, limited by shares, registered in England and Wales, registration number 13241068. The registered office is 8b Brick Lane, London, E1 6RF, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
25% reducing balance
Computer equipment
25% reducing balance
4
Tangible fixed assets
Fixtures & fittings 
Computer equipment 
Total 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At 1 April 2022
196 
826 
1,022 
Additions
- 
836 
836 
At 31 March 2023
196 
1,662 
1,858 
Depreciation
At 1 April 2022
20 
86 
106 
Charge for the year
44 
341 
385 
At 31 March 2023
64 
427 
491 
Net book value
At 31 March 2023
132 
1,235 
1,367 
At 31 March 2022
176 
740 
916 
- 6 -
Antevasin Ltd Notes to the Accounts for the year ended 31 March 2023
5
Debtors
2023 
2022 
£ 
£ 
Amounts falling due within one year
Other debtors
1,272 
3,193 
6
Creditors: amounts falling due within one year
2023 
2022 
£ 
£ 
Taxes and social security
6,725 
3,070 
Other creditors
- 
737 
Loans from directors
245 
- 
Accruals
636 
885 
7,606 
4,692 
7
Share capital
2023 
2022 
£ 
£ 
Allotted, called up and fully paid:
1 Ordinary shares of £1 each
1 
1 
8
Loans to directors
Brought Forward 
Advance/ credit 
Repaid 
Carried Forward 
£ 
£ 
£ 
£ 
Ms Beatrice Gallo
Director Loan Account
1,922 
(11,000)
(8,833)
(245)
1,922 
(11,000)
(8,833)
(245)
9
Average number of employees
During the year the average number of employees was 1 (2022: 1).
- 7 -